We observed no evidence of any clear associations for the other subtypes, and in fact a reduced OR for the luminal B-like HER2-positive (OR = 0.51, 95% CI 0.27–0.96) subtype (p-heterogeneity with luminal A-like breast cancer = 0.009) (Table 3). Here, ERBB2 is linked to breast cancer.